ResearcherMicrobial Chemistry Research FoundationActive in the last 2 years
Manabu Kawada
Matched on ORCID iD 0000-0001-9348-4240; OpenAlex author ID A5064054143. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 7
2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers
Papers 7
- TKTL1 mediates metabolic adaptation and stress resistance in pancreatic cancer cells under nutrient-deprived conditions. Co-author DOI 10.1038/s41388-026-03913-7↗
- SUSD2 Promotes Metastasis and Primary Tumor Growth in Pancreatic Cancer Cells via Integrin-FAK Signaling Activation. Last author DOI 10.1111/cas.70318↗
- New oligomycin derivatives inhibit anchorage-independent growth of pancreatic cancer cells. Last author DOI 10.1038/s41429-025-00832-9↗
- Two new adenopeptins B and C inhibit sphere formation of pancreatic cancer cells. Last author DOI 10.1038/s41429-023-00679-y↗
- Pancreatic Stromal Cell-derived Oncostatin M Confers Drug Resistance to a Multi-tyrosine Kinase Inhibitor in Pancreatic Cancer Cells. Last author DOI 10.21873/anticanres.16415↗
- Human pancreatic cancer cells under nutrient deprivation are vulnerable to redox system inhibition. Last author DOI 10.1074/jbc.ra120.013893↗
- H2Mab-19 Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody Therapy Exerts Antitumor Activity in Pancreatic Cancer Xenograft Models. Co-author DOI 10.1089/mab.2020.0011↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Daisuke Tatsuda · 4 shared papers, 2023–2026 · strength 1.00
- Paper SUSD2 Promotes Metastasis and Primary Tumor Growth in Pancreatic Cancer Cells via Integrin-FAK Signaling Activation. DOI 10.1111/cas.70318↗
- Paper Pancreatic Stromal Cell-derived Oncostatin M Confers Drug Resistance to a Multi-tyrosine Kinase Inhibitor in Pancreatic… DOI 10.21873/anticanres.16415↗
- Paper New oligomycin derivatives inhibit anchorage-independent growth of pancreatic cancer cells. DOI 10.1038/s41429-025-00832-9↗
- Junjiro Yoshida · 4 shared papers, 2023–2026 · strength 1.00
- Paper SUSD2 Promotes Metastasis and Primary Tumor Growth in Pancreatic Cancer Cells via Integrin-FAK Signaling Activation. DOI 10.1111/cas.70318↗
- Paper Pancreatic Stromal Cell-derived Oncostatin M Confers Drug Resistance to a Multi-tyrosine Kinase Inhibitor in Pancreatic… DOI 10.21873/anticanres.16415↗
- Paper New oligomycin derivatives inhibit anchorage-independent growth of pancreatic cancer cells. DOI 10.1038/s41429-025-00832-9↗
- Isao Momose · 3 shared papers, 2020–2026 · strength 0.78
- Paper TKTL1 mediates metabolic adaptation and stress resistance in pancreatic cancer cells under nutrient-deprived conditions. DOI 10.1038/s41388-026-03913-7↗
- Paper SUSD2 Promotes Metastasis and Primary Tumor Growth in Pancreatic Cancer Cells via Integrin-FAK Signaling Activation. DOI 10.1111/cas.70318↗
- Paper Human pancreatic cancer cells under nutrient deprivation are vulnerable to redox system inhibition. DOI 10.1074/jbc.ra120.013893↗
- Takefumi Onodera · 2 shared papers, 2020–2026 · strength 0.51
- Atsushi Masamune · 1 shared paper, 2026 · strength 0.27
- Yukinari Kato · 1 shared paper, 2020 · strength 0.12
- Mika Kato Kaneko · 1 shared paper, 2020 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.